These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 15358945

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y, Erez E, Vidne B, Birk E, Katz J, Tamari H, Dagan O.
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F, Castillo JG, Rahmanian PB, Scurlock C, Fischer G, Adams DH.
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [Abstract] [Full Text] [Related]

  • 6. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
    Agarwal HS, Bennett JE, Churchwell KB, Christian KG, Drinkwater DC, He Y, Taylor MB.
    Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
    [Abstract] [Full Text] [Related]

  • 7. Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy.
    Ekert H, Brizard C, Eyers R, Cochrane A, Henning R.
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):389-95. PubMed ID: 16788315
    [Abstract] [Full Text] [Related]

  • 8. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ.
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
    [Abstract] [Full Text] [Related]

  • 9. Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery.
    McCall P, Story DA, Karalapillai D.
    Can J Anaesth; 2006 Sep; 53(9):926-33. PubMed ID: 16960271
    [Abstract] [Full Text] [Related]

  • 10. Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery?
    Okonta KE, Edwin F, Falase B.
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):690-4. PubMed ID: 22811512
    [Abstract] [Full Text] [Related]

  • 11. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass.
    Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.
    Paediatr Anaesth; 2009 Apr; 19(4):364-70. PubMed ID: 19143947
    [Abstract] [Full Text] [Related]

  • 12. Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.
    Karsies TJ, Nicol KK, Galantowicz ME, Stephens JA, Kerlin BA.
    Ann Thorac Surg; 2010 Feb; 89(2):570-6. PubMed ID: 20103344
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recombinant activated factor VII following pediatric cardiac surgery.
    Kylasam S, Mos K, Fijtin S, Webster B, Chard R, Egan J.
    J Intensive Care Med; 2009 Feb; 24(2):116-21. PubMed ID: 19188273
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A Propensity-Score Matched Analysis on Outcomes Using Recombinant Activated Factor VII in Pediatric Cardiac Surgery.
    Li Y, Zhao W, Luo Q, Wu X, Ding J, Yan F.
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1269-1275. PubMed ID: 30795967
    [Abstract] [Full Text] [Related]

  • 19. [The use of recombinant activated factor VII for blood loss after cardiovascular surgery].
    Gong ZY, Gao CQ, Xiao CS, Li BJ, Ma XH, Zhang CM.
    Zhonghua Wai Ke Za Zhi; 2008 Oct 01; 46(19):1497-501. PubMed ID: 19094631
    [Abstract] [Full Text] [Related]

  • 20. Recombinant factor VIIa use in cardiac surgery--expanding the arsenal therapy for intractable bleeding?
    Kogan A, Berman M, Stein M, Vidne BA, Raanani E.
    J Cardiovasc Surg (Torino); 2004 Dec 01; 45(6):569-71. PubMed ID: 15746637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.